Insuffisance cardiaque chez les sujets âgés de plus de 80 ans
| Autor: | L. Hittinger, Carmelo Lafuente-Lafuente, Emmanuelle Berthelot, Charlotte Nouhaud, Patrick Assayag |
|---|---|
| Přispěvatelé: | Service de Gériatrie à orientation cardiologique et neurologique, CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12) |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Pediatrics
medicine.medical_specialty medicine.drug_class business.industry Incidence (epidemiology) [SDV]Life Sciences [q-bio] MEDLINE General Medicine 030204 cardiovascular system & hematology Therapeutic education medicine.disease 3. Good health 03 medical and health sciences 0302 clinical medicine Heart failure Edema Natriuretic peptide medicine 030212 general & internal medicine medicine.symptom business Weight gain Clinical syndrome |
| Zdroj: | La Presse Médicale La Presse Médicale, Elsevier Masson, 2019, 48, pp.143-153. ⟨10.1016/j.lpm.2019.02.001⟩ |
| ISSN: | 0755-4982 2213-0276 |
| DOI: | 10.1016/j.lpm.2019.02.001⟩ |
| Popis: | Heart failure (HF) is a clinical syndrome that associates clinical signs in people over 80 years of age, an increase in natriuretic peptides and abnormal cardiac structures that result from cardiac aging in many cases. The most common symptoms are grouped according to the acronym "EPOF" (shortness of breath, weight gain, edema, fatigue). Over the age of 80, comorbidities must be taken into account. The incidence and prevalence of HF significantly increases with age and makes HF the most common reason for hospitalization for people over 80, and an important health expense. The management of HF, necessarily multidisciplinary with a geriatric evaluation, has improved over time due to effective targeted treatment, but mortality, hospitalization and readmission rates remain high. Therapeutic education and patient follow-up for treatment optimization are needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect